2-[(Z)-5-(2,4-dimethoxyphenyl)pent-4-enoxy]oxane | 1206193-24-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-[(Z)-5-(2,4-dimethoxyphenyl)pent-4-enoxy]oxane
• CAS: 1206193-24-9
• 化学式: C₁₈H₂₆O₄
• 分子量: 306.402
• InChiKey: XMWHUPPMDOFVJI-YWEYNIOJSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  22
• 可旋转键数：
  8
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.56
• 拓扑面积：
  36.9
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  4-(四氢-2H-吡喃-2-基氧基)丁醛 、 (2,4-dimethoxybenzyl)triphenylphosphonium bromide 在 正丁基锂 作用下， 以 四氢呋喃 、 正己烷 为溶剂， 生成 2-[(Z)-5-(2,4-dimethoxyphenyl)pent-4-enoxy]oxane 、
  参考文献：
  名称：

  SERIES OF SKIN WHITENING (LIGHTENING) COMPOUNDS

  摘要：

  本发明涉及酪氨酸酶抑制剂，包含此类酪氨酸酶抑制剂的药物组合物，以及制备和使用这些药物的方法。具体而言，本发明包括至少一种2,4-二羟基苯类似物组成的物质组合物，这些组合物抑制酪氨酸酶的活性并抑制黑色素的过度产生。

  公开号：

  US20100016347A1

文献信息

• SERIES OF SKIN-WHITENING (LIGHTENING) COMPOUNDS
  申请人：Unigen, Inc.

  公开号：US20160083322A1

  公开（公告）日：2016-03-24

  The present invention is directed to inhibitors of tyrosinase, pharmaceutical compositions comprising such tyrosinase inhibitors, and methods of making and using the same. Specifically, included in the present invention are compositions of matter comprised of at least one 2,4-dihydroxybenzene analog, which inhibit the activity of tyrosinase and which inhibit the overproduction of melanin.

  本发明涉及酪氨酸酶抑制剂、包含这种酪氨酸酶抑制剂的药物组合物以及制备和使用它们的方法。具体而言，本发明包括由至少一种2,4-二羟基苯类似物组成的物质组合物，其抑制酪氨酸酶活性并抑制黑色素的过度生产。
• Series of skin whitening (lightening) compounds
  申请人：Unigen, Inc.

  公开号：US10259764B2

  公开（公告）日：2019-04-16

  The present invention is directed to inhibitors of tyrosinase, pharmaceutical compositions comprising such tyrosinase inhibitors, and methods of making and using the same. Specifically, included in the present invention are compositions of matter comprised of at least one 2,4-dihydroxybenzene analog, which inhibit the activity of tyrosinase and which inhibit the overproduction of melanin.

  本发明涉及酪氨酸酶抑制剂、包含这种酪氨酸酶抑制剂的药物组合物以及制造和使用这些药物组合物的方法。具体地说，本发明包括由至少一种 2,4-二羟基苯类似物组成的物质组合物，这种物质组合物能抑制酪氨酸酶的活性，并能抑制黑色素的过度生成。
• Series of Skin Whitening (Lightening) Compounds
  申请人：Unigen, Inc.

  公开号：US20170275224A1

  公开（公告）日：2017-09-28

  The present invention is directed to inhibitors of tyrosinase, pharmaceutical compositions comprising such tyrosinase inhibitors, and methods of making and using the same. Specifically, included in the present invention are compositions of matter comprised of at least one 2,4-dihydroxybenzene analog, which inhibit the activity of tyrosinase and which inhibit the overproduction of melanin.
• Series of Skin-Whitening (Lightening) Compounds
  申请人：Unigen, Inc.

  公开号：US20210188751A1

  公开（公告）日：2021-06-24

  The present invention is directed to inhibitors of tyrosinase, pharmaceutical compositions comprising such tyrosinase inhibitors, and methods of making and using the same. Specifically, included in the present invention are compositions of matter comprised of at least one 2,4-dihydroxybenzene analog, which inhibit the activity of tyrosinase and which inhibit the overproduction of melanin.
• US8362305B2
  申请人：——

  公开号：US8362305B2

  公开（公告）日：2013-01-29